Information:
Fel:
ID
13060
Beskrivning
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00083577
Länk
https://clinicaltrials.gov/show/NCT00083577
Nyckelord
Versioner (1)
- 2016-01-13 2016-01-13 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
13 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Multiple Myeloma NCT00083577
Eligibility Multiple Myeloma NCT00083577
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00083577
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
multiple myeloma
Item
all patients must have a confirmed diagnosis of previously treated, active multiple myeloma
boolean
C0026764 (UMLS CUI [1])
myeloma protein
Item
myeloma protein should be evident from which to evaluate response
boolean
C0027015 (UMLS CUI [1])
age, contraception
Item
must be 18 years of age or older. women of childbearing age and fertile men must use a medically acceptable means of birth control while on study and for 6 months thereafter.
boolean
C0001779 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
informed consent
Item
patients must sign an informed consent to participate in this study, and be fully aware of the known teratogenic potential of this drug
boolean
C0021430 (UMLS CUI [1])
white blood cell count
Item
patients must have a total white blood cell count of 2,000 k/microliters. patients may be anemic or thrombocytopenic provided this is felt to be due to extensive marrow involvement with myeloma
boolean
C0023508 (UMLS CUI [1])
liver function
Item
patients must have adequate liver function as demonstrated by a direct bilirubin of < or = 2.0 mg/dl.
boolean
C1278039 (UMLS CUI [1])
active infection
Item
patients must not have an active infection requiring parenteral antibiotics
boolean
C0009450 (UMLS CUI [1])
concurrent therapy
Item
no other concurrent therapy for myeloma is permitted while on thalidomide
boolean
C0039736 (UMLS CUI [1])